|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Drug Monitoring, Tapentadol, Quantitative, Urine
Test Code90243
CPT Codes
80372 (HCPCS: G0480)
Includes
Tapentadol, Nortapentadol
Preferred Specimen
20 mL random urine collected in a clinical drug test transport vial
Minimum Volume
5 mL
Other Acceptable Specimens
Urine collected in urine collection container
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 5 days
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Preserved samples
Methodology
Mass Spectrometry (MS)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 3 days
Reference Range
Tapentadol | <50 ng/mL |
Nortapentadol | <50 ng/mL |
Clinical Significance
The purpose of this test is to determine the presence of
Tapentadol and N-Desmethyltapentadol (metabolite) in
urine. The results of this test are used in specific
therapeutic treatment programs and Pain Management
settings to determine compliance with prescribed dosing
schedules.
Tapentadol and N-Desmethyltapentadol (metabolite) in
urine. The results of this test are used in specific
therapeutic treatment programs and Pain Management
settings to determine compliance with prescribed dosing
schedules.